Asima Health is developing a multi-cancer blood test to reduce the human and financial burden of post-cancer testing...
Our innovative technology can quickly rule out cancer or identify those at risk and in need of colonoscopy, mammography, etc., with a simple blood test.
Our platform technology is portable which means that the test can be accessed through any local diagnostic lab, as part of routine blood work.
Our pan-genomic test can simultaneously detect multiple cancers which means primary & secondary cancers can be caught through a single blood draw.
Early cancer detection can save lives
More people are surviving cancer. Between 1991 & 2020, the death rate for all cancers in the U.S. declined by 33%. Currently there are 18 million cancer survivors in the U.S and this number is projected to become 26 million by 2040.
Cancer survivors follow up with their doctor every 3-12 mos for a physical exam & testing. The standard of care involves tests such as mammograms and colonoscopy, that are invasive, expensive, slow to get results, and have low diagnostic yield.